Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opsens Inc V.OPS


Primary Symbol: T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.


TSX:OPS - Post by User

Comment by bossuon Oct 24, 2022 12:28pm
129 Views
Post# 35044005

RE:RE:My view...

RE:RE:My view...'''kind'a
betted the farm on it!'''
Just to say that betting BIG on OPS is certainly not to the way to invest but it's up to you .
You must have read that when you invest you have to be prepare to see your investment shrink and stay in the ''basement''for a long period of time.
What we have to see from Opsens is a bigger revenues  in the Q4 than the Q3 which was $ 10 076 000 .for a total of $ 26 399 000 so far this year and a 2022 total revenues of $ $ 38 or more for a 10 % increase on Y/Y
By the way revenues in 2021 was $ 34 864 000 
Revenues  for 2023 have to be way higher to reach their 2025 goal published not long ago and they have made big investment in the sales and maketing during the year .
Now is the time to see ''growth'' and their product is exceptional and approved by the FDA and Canadian Health and soon to receive the Europen clearance .
The market is soon to be  opened  all around the globe .






<< Previous
Bullboard Posts
Next >>